ERX-1000

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameERX-1000
Drug Alias NameERX-1000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeptin receptor agonists
TargetsLeptin receptor
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesERX Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesERX Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A